A prospective, randomized controlled trial comparing the efficacy of recombinant follicle-stimulating hormone in three different in vitro fertilization protocols-Reference-Cited by-同舟云学术

A prospective, randomized controlled trial comparing the efficacy of recombinant follicle-stimulating hormone in three different in vitro fertilization protocols

Published:2000-05 Issue:5 Volume:73 Page:908-912
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Ravhon Amir,Lawrie Henrietta,Ellenbogen Adrian,Lavery Stuart,Trew Geoffrey,Winston Robert

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference28 articles.

1. Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with human menopausal gonadotropins;Wildt;Hum Reprod,1986

2. Suppression of the ovary using a gonadotropin releasing-hormone agonist prior to stimulation for oocyte retrieval;de Ziegler;Fertil Steril,1987

3. Ovarian stimulation for in vitro fertilisation combining administration of gonadotropins and blockade of the pituitary with D-Try6-LHRH microcapsules;Zorn;Hum Reprod,1988

4. Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program;Frydman;Fertil Steril,1988

5. Hormonal changes induced by short-term administration of a gonadotropin-releasing hormone agonist during ovarian hyperstimulation for in vitro fertilization and their consequences for embryo development;Loumaye;Fertil Steril,1989

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pituitary suppression with a GnRHa short protocol in an alternate day schedule associated with rhCG microdoses;JBRA Assisted Reproduction;2014

2. Comparison of outcomes and direct cost between minimal stimulation and conventional protocols on ovarian stimulation in in vitro fertilization;Journal of Obstetrics and Gynaecology Research;2005-10

3. Optimizing gonadotrophin-releasing hormone antagonist protocols;Human Fertility;2002-01